Cowen Maintains Buy on TECH (Bio-Techne Corporation) March 17, 2026

robot
Abstract generation in progress

Cowen & Co. reaffirmed its “Buy” rating on Bio-Techne Corporation (TECH) on March 17, 2026, viewing a recent stock sell-off as “overdone” and an opportunity for long-term investors to buy on weakness. Although no new price target was issued, the firm’s stance signals continued confidence in TECH’s fundamentals despite short-term market fluctuations. Meyka AI independently rates TECH with a “B+” grade, further affirming its positive long-term prospects.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin